Puma Biotechnology (PBYI) Consolidated Net Income (2017 - 2025)
Historic Consolidated Net Income for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $8.8 million.
- Puma Biotechnology's Consolidated Net Income fell 5647.0% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year increase of 2866.49%. This contributed to the annual value of $23.2 million for FY2024, which is 746.61% up from last year.
- Latest data reveals that Puma Biotechnology reported Consolidated Net Income of $8.8 million as of Q3 2025, which was down 5647.0% from $5.9 million recorded in Q2 2025.
- Puma Biotechnology's Consolidated Net Income's 5-year high stood at $20.3 million during Q3 2024, with a 5-year trough of -$44.7 million in Q3 2021.
- Over the past 5 years, Puma Biotechnology's median Consolidated Net Income value was $3.0 million (recorded in 2025), while the average stood at $1.8 million.
- Per our database at Business Quant, Puma Biotechnology's Consolidated Net Income skyrocketed by 171000.0% in 2023 and then plummeted by 44368.31% in 2024.
- Quarter analysis of 5 years shows Puma Biotechnology's Consolidated Net Income stood at $4.2 million in 2021, then tumbled by 232.72% to -$5.6 million in 2022, then soared by 318.84% to $12.3 million in 2023, then dropped by 0.31% to $12.2 million in 2024, then decreased by 27.69% to $8.8 million in 2025.
- Its last three reported values are $8.8 million in Q3 2025, $5.9 million for Q2 2025, and $3.0 million during Q1 2025.